Tissue‐Adaptive BSA Hydrogel with Dual Release of PTX and bFGF Promotes Spinal Cord Injury Repair via Glial Scar Inhibition and Axon Regeneration
Authors:
Abstract
Spinal cord injury (SCI) is a severe clinical disease usually accompanied by activated glial scar, neuronal axon rupture, and disabled motor function. To mimic the microenvironment of the SCI injury site, a hydrogel system with a comparable mechanical property to the spinal cord is desirable. Therefore, a novel elastic bovine serum albumin (BSA) hydrogel is fabricated with excellent adhesive, injectable, and biocompatible properties. The hydrogel is used to deliver paclitaxel (PTX) together with basic fibroblast growth factor (bFGF) to inhibit glial scar formation as well as promote axon regeneration and motor function for SCI repair. Due to the specific interaction of BSA with both drugs, bFGF, and PTX can be controllably released from the hydrogel system to achieve an effective concentration at the wound site during the SCI regeneration process. Moreover, benefiting from the combination of PTX and bFGF, this bFGF/PTX@BSA system significantly aided axon repair by promoting the elongation of axons across the glial scar with reduced reactive astrocyte secretion. In addition, remarkable anti‐apoptosis of nerve cells is evident with the bFGF/PTX@BSA system. Subsequently, this multi‐functionalized drug system significantly improved the motor function of the rats after SCI. These results reveal that bFGF/PTX@BSA is an ideal functionalized material for nerve repair in SCI.Keywords
Funding Information
- National Natural Science Foundation of China (82172226)
- Natural Science Foundation of Zhejiang Province (LY21H180005)
This publication has 49 references indexed in Scilit:
- Multifunctional Conductive and Electrogenic Hydrogel Repaired Spinal Cord Injury via Immunoregulation and Enhancement of Neuronal DifferentiationAdvanced Materials, 2024
- Injectable Hydrogel System Incorporating Black Phosphorus Nanosheets and Tazarotene Drug for Enhanced Vascular and Nerve Regeneration in Spinal Cord Injury RepairSmall, 2024
- A Bioinspired Injectable, Adhesive, and Self‐Healing Hydrogel with Dual Hybrid Network for Neural Regeneration after Spinal Cord InjuryAdvanced Materials, 2023
- ROS‐Scavenging Hydrogels Synergize with Neural Stem Cells to Enhance Spinal Cord Injury Repair via Regulating Microenvironment and Facilitating Nerve RegenerationAdvanced Healthcare Materials, 2023
- A General Protein Unfolding‐Chemical Coupling Strategy for Pure Protein Hydrogels with Mechanically Strong and Multifunctional PropertiesAdvanced Science, 2021
- Alginate self-adhesive hydrogel combined with dental pulp stem cells and FGF21 repairs hemisection spinal cord injury via apoptosis and autophagy mechanismsChemical Engineering Journal, 2021
- Co-delivery of minocycline and paclitaxel from injectable hydrogel for treatment of spinal cord injuryJournal of Controlled Release, 2020
- Sustained release and protein stabilization reduce the growth factor dosage required for human pluripotent stem cell expansionBiomaterials, 2020
- Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumorsBiomaterials, 2018
- Serum albumin improves recovery from spinal cord injuryJournal of Neuroscience Research, 2007